Gene: RMDN2
Official Full Name: regulator of microtubule dynamics 2provided by HGNC
Gene Summary: Enables microtubule binding activity. Located in Golgi apparatus; cytosol; and spindle. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21973 | RMDN2 Knockout cell line (HeLa) | Human | RMDN2 | 1:3~1:6 | Negative | Online Inquiry |
KO21974 | RMDN2 Knockout cell line (HCT 116) | Human | RMDN2 | 1:2~1:4 | Negative | Online Inquiry |
KO21975 | RMDN2 Knockout cell line (HEK293) | Human | RMDN2 | 1:3~1:6 | Negative | Online Inquiry |
KO21976 | RMDN2 Knockout cell line (A549) | Human | RMDN2 | 1:3~1:4 | Negative | Online Inquiry |
RMDN2 Gene Knockout Cell Lines are genetically engineered cell lines designed to aid in the study of the RMDN2 gene's function by completely eliminating its expression. These cell lines are created using advanced CRISPR-Cas9 technology, enabling highly precise modifications of the genome. The knockout of the RMDN2 gene allows researchers to investigate its biological roles and the molecular pathways it influences, particularly in cellular processes such as ribosome biogenesis and stress response mechanisms.
The key function of the RMDN2 Gene Knockout Cell Lines lies in their ability to provide a controlled environment in which the absence of the RMDN2 protein can be studied. By observing the resulting phenotypic and molecular changes, researchers can uncover essential insights into the gene's implications in various physiological and pathological conditions, including some cancers and neurodegenerative diseases.
In the scientific community, these cell lines are invaluable for both basic research and therapeutic development. Their application extends to high-throughput screening for potential drug candidates and the elucidation of gene interactions in complex biological networks, thereby facilitating a deeper understanding of disease mechanisms.
What sets RMDN2 Gene Knockout Cell Lines apart from alternative models—such as non-targeted knockouts or overexpression systems—is their specificity and reliability. These cell lines provide a consistent genetic background, ensuring that observed effects are attributable solely to the manipulation of the RMDN2 gene.
For researchers and clinicians, investing in RMDN2 Gene Knockout Cell Lines enhances the comprehensiveness of studies aimed at translational applications. Understanding the role of RMDN2 could lead to novel therapeutic strategies or biomarkers for diagnosis, which are increasingly critical in precision medicine.
With a long-standing commitment to excellence in genetic engineering, our company offers a robust portfolio of biologically relevant tools and resources, ensuring the highest standards for research integrity and innovation. With RMDN2 Gene Knockout Cell Lines, your path to groundbreaking discoveries is significantly broadened.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.